<code id='84CEFEE9A4'></code><style id='84CEFEE9A4'></style>
    • <acronym id='84CEFEE9A4'></acronym>
      <center id='84CEFEE9A4'><center id='84CEFEE9A4'><tfoot id='84CEFEE9A4'></tfoot></center><abbr id='84CEFEE9A4'><dir id='84CEFEE9A4'><tfoot id='84CEFEE9A4'></tfoot><noframes id='84CEFEE9A4'>

    • <optgroup id='84CEFEE9A4'><strike id='84CEFEE9A4'><sup id='84CEFEE9A4'></sup></strike><code id='84CEFEE9A4'></code></optgroup>
        1. <b id='84CEFEE9A4'><label id='84CEFEE9A4'><select id='84CEFEE9A4'><dt id='84CEFEE9A4'><span id='84CEFEE9A4'></span></dt></select></label></b><u id='84CEFEE9A4'></u>
          <i id='84CEFEE9A4'><strike id='84CEFEE9A4'><tt id='84CEFEE9A4'><pre id='84CEFEE9A4'></pre></tt></strike></i>

          fashion

          fashion

          author:comprehensive    Page View:6954
          An FDA sign — health policy coverage from STAT
          Sarah Silbiger/Getty Images

          WASHINGTON — There’s about to be a new acronym in town.

          The Food and Drug Administration is in the final stages of cementing sweeping changes to the Office of Regulatory Affairs, which oversees inspections and compliance for all its regulated products, according to three people familiar with the planning.

          advertisement

          That overhaul includes a new name: Meet the Office of Inspections and Investigations.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more
          Congress extends some pandemic preparedness programs
          Congress extends some pandemic preparedness programs

          STEFANIREYNOLDS/AFPviaGettyImagesWASHINGTON—Congresstemporarilyextendedafewpandemic-preparednessprog

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          Hospitals struggle to profit from CAR

          MedicaregenerallypaysfarmoreforCAR-Tdrugsthatareadministeredinoutpatientdepartmentsthanitdoesforinpa